Import duties on pharmaceutical manufacturing inputs such as APIs cost patients US$1.2bn in the US and US$1.1bn in the EU, find Philipp Lamprecht and Matthias Bauer in this new Geneva Network working paper.
An international coalition of think tanks calls on governments to reject a proposal at the WTO to waive intellectual property rights for Covid vaccines
The UK, EU and other allies should speak out against the badly thought out proposal before the WTO.
The IP system has been crucial in underpinning the research, development and manufacture of vaccines and therapeutics for COVID-19, proving critics of IP wrong at every step of this crisis.
Experts from the life science and research community explain the crucial role of intellectual property rights in developing new vaccines and therapeutics for Covid-19.
Expertos de la comunidad de las biociencias y la investigación explican el rol fundamental que juegan los derechos de propiedad intelectual en el desarrollo de vacunas y tratamientos contra la Covid-19.